Cargando…

Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection

BACKGROUND: The clinical syndrome of disseminated nontuberculous mycobacterial (NTM) infection in patients who were previously healthy is now well recognized to be associated with an acquired autoantibody to Interferon gamma (Anti IFN- γ autoantibody). However, the risk factors of this syndrome rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Phoompoung, Pakpoom, Ankasekwinai, Nasikarn, Pithukpakorn, Manop, Foongladda, Suporn, Umrod, Pinklow, Suktitipat, Bhoom, Mahasirimongkol, Surakameth, Kiertiburanakul, Sasisopin, Suputtamongkol, Yupin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402934/
https://www.ncbi.nlm.nih.gov/pubmed/28437431
http://dx.doi.org/10.1371/journal.pone.0176342
_version_ 1783231328416694272
author Phoompoung, Pakpoom
Ankasekwinai, Nasikarn
Pithukpakorn, Manop
Foongladda, Suporn
Umrod, Pinklow
Suktitipat, Bhoom
Mahasirimongkol, Surakameth
Kiertiburanakul, Sasisopin
Suputtamongkol, Yupin
author_facet Phoompoung, Pakpoom
Ankasekwinai, Nasikarn
Pithukpakorn, Manop
Foongladda, Suporn
Umrod, Pinklow
Suktitipat, Bhoom
Mahasirimongkol, Surakameth
Kiertiburanakul, Sasisopin
Suputtamongkol, Yupin
author_sort Phoompoung, Pakpoom
collection PubMed
description BACKGROUND: The clinical syndrome of disseminated nontuberculous mycobacterial (NTM) infection in patients who were previously healthy is now well recognized to be associated with an acquired autoantibody to Interferon gamma (Anti IFN- γ autoantibody). However, the risk factors of this syndrome remain unknown. METHOD: We performed an unmatched case control study among patients with NTM diseases who were diagnosed and treated at Siriraj Hospital, Bangkok, Thailand. Anti-IFN autoantibody was detected by enzyme-linked immunosorbent assay (ELISA) method. Cases were patients with NTM diseases and detectable anti IFN- γ autoantibody. Controls were randomly selected from those with undetectable anti IFN- γ autoantibody. Data from both groups including demographic data, clinical presentation, laboratory results, other risk factors and HLA genotypes were collected. Univariate and multivariate analyses were performed to identify independent risk factors for this syndrome. RESULTS: 70 cases (mean age 50 ± 11 years) and 70 controls (mean age 58 ± 18 years) were enrolled into the study. Mycobacterial abscessus was the most common NTM pathogen found in both groups (72.9% in cases and 41.4% in controls respectively). However, disseminated NTM disease was significantly more common in cases (92.9%) than in the controls (14.3%, p<0.001). Binary logistic regression analysis showed that previous OIs (adjusted OR14.87, 95% CI 2.36–93.86), birthplace outside Central region (adjusted OR 19.19, 95% CI 3.86–95.35), lack of comorbidities lead to immunosuppression, such as HIV infection or diabetes mellitus (adjusted OR 23.68, 95% CI 4.01–139.94), and presence of HLA DRB1*15/16 (adjusted OR 153.28, 95% CI 16.87–139.88) were independent factors associated with this syndrome. CONCLUSION: Patients with NTM disease associated with anti IFN- γ autoantibody are almost always previously healthy and HIV negative. Most of these patients presented with disseminated NTM disease with generalized lymphadenitis and often with reactive skin lesions. Factors associated with detectable anti IFN- γ autoantibody are HLA-DRB1 and DQB1 alleles, and history of previous OIs in patients without comorbidity that leads to immunosuppression. Further studies are needed to better understand these associations and to improve the treatment outcome.
format Online
Article
Text
id pubmed-5402934
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54029342017-05-12 Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection Phoompoung, Pakpoom Ankasekwinai, Nasikarn Pithukpakorn, Manop Foongladda, Suporn Umrod, Pinklow Suktitipat, Bhoom Mahasirimongkol, Surakameth Kiertiburanakul, Sasisopin Suputtamongkol, Yupin PLoS One Research Article BACKGROUND: The clinical syndrome of disseminated nontuberculous mycobacterial (NTM) infection in patients who were previously healthy is now well recognized to be associated with an acquired autoantibody to Interferon gamma (Anti IFN- γ autoantibody). However, the risk factors of this syndrome remain unknown. METHOD: We performed an unmatched case control study among patients with NTM diseases who were diagnosed and treated at Siriraj Hospital, Bangkok, Thailand. Anti-IFN autoantibody was detected by enzyme-linked immunosorbent assay (ELISA) method. Cases were patients with NTM diseases and detectable anti IFN- γ autoantibody. Controls were randomly selected from those with undetectable anti IFN- γ autoantibody. Data from both groups including demographic data, clinical presentation, laboratory results, other risk factors and HLA genotypes were collected. Univariate and multivariate analyses were performed to identify independent risk factors for this syndrome. RESULTS: 70 cases (mean age 50 ± 11 years) and 70 controls (mean age 58 ± 18 years) were enrolled into the study. Mycobacterial abscessus was the most common NTM pathogen found in both groups (72.9% in cases and 41.4% in controls respectively). However, disseminated NTM disease was significantly more common in cases (92.9%) than in the controls (14.3%, p<0.001). Binary logistic regression analysis showed that previous OIs (adjusted OR14.87, 95% CI 2.36–93.86), birthplace outside Central region (adjusted OR 19.19, 95% CI 3.86–95.35), lack of comorbidities lead to immunosuppression, such as HIV infection or diabetes mellitus (adjusted OR 23.68, 95% CI 4.01–139.94), and presence of HLA DRB1*15/16 (adjusted OR 153.28, 95% CI 16.87–139.88) were independent factors associated with this syndrome. CONCLUSION: Patients with NTM disease associated with anti IFN- γ autoantibody are almost always previously healthy and HIV negative. Most of these patients presented with disseminated NTM disease with generalized lymphadenitis and often with reactive skin lesions. Factors associated with detectable anti IFN- γ autoantibody are HLA-DRB1 and DQB1 alleles, and history of previous OIs in patients without comorbidity that leads to immunosuppression. Further studies are needed to better understand these associations and to improve the treatment outcome. Public Library of Science 2017-04-24 /pmc/articles/PMC5402934/ /pubmed/28437431 http://dx.doi.org/10.1371/journal.pone.0176342 Text en © 2017 Phoompoung et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Phoompoung, Pakpoom
Ankasekwinai, Nasikarn
Pithukpakorn, Manop
Foongladda, Suporn
Umrod, Pinklow
Suktitipat, Bhoom
Mahasirimongkol, Surakameth
Kiertiburanakul, Sasisopin
Suputtamongkol, Yupin
Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
title Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
title_full Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
title_fullStr Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
title_full_unstemmed Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
title_short Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
title_sort factors associated with acquired anti ifn- γ autoantibody in patients with nontuberculous mycobacterial infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402934/
https://www.ncbi.nlm.nih.gov/pubmed/28437431
http://dx.doi.org/10.1371/journal.pone.0176342
work_keys_str_mv AT phoompoungpakpoom factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT ankasekwinainasikarn factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT pithukpakornmanop factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT foongladdasuporn factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT umrodpinklow factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT suktitipatbhoom factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT mahasirimongkolsurakameth factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT kiertiburanakulsasisopin factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection
AT suputtamongkolyupin factorsassociatedwithacquiredantiifngautoantibodyinpatientswithnontuberculousmycobacterialinfection